Clinical Trial Update: Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial updating combination chemotherapy, peripheral stem cell transplant, biological therapy, pamidronate, and thalidomide in multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Pamidronate (pamidronate disodium)
• Thalidomide (thalidomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2019-07-02